288 related articles for article (PubMed ID: 29685291)
1. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against metabotropic glutamate receptor type 1 in a toddler with acute cerebellitis.
Bien CG; Braig S; Bien CI
J Neuroimmunol; 2020 Nov; 348():577366. PubMed ID: 32861169
[TBL] [Abstract][Full Text] [Related]
3. Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
Spatola M; Petit Pedrol M; Maudes E; Simabukuro M; Muñiz-Castrillo S; Pinto AL; Wandinger KP; Spiegler J; Schramm P; Dutra LA; Iorio R; Kornblum C; Bien CG; Höftberger R; Leypoldt F; Titulaer MJ; Sillevis Smitt P; Honnorat J; Rosenfeld MR; Graus F; Dalmau J
Neurology; 2020 Dec; 95(22):e3012-e3025. PubMed ID: 32928978
[TBL] [Abstract][Full Text] [Related]
4. Fundamental Mechanisms of Autoantibody-Induced Impairments on Ion Channels and Synapses in Immune-Mediated Cerebellar Ataxias.
Mitoma H; Honnorat J; Yamaguchi K; Manto M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668612
[TBL] [Abstract][Full Text] [Related]
5. Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.
Liu M; Ren H; Fan S; Zhang W; Xu Y; Zhao W; Guan H;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580182
[TBL] [Abstract][Full Text] [Related]
6. Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
Wang J; Qiu Z; Li D; Dong H; Hao J; Liu Z
J Neuroimmunol; 2021 Apr; 353():577515. PubMed ID: 33640718
[TBL] [Abstract][Full Text] [Related]
7. Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?
Marignier R; Chenevier F; Rogemond V; Sillevis Smitt P; Renoux C; Cavillon G; Androdias G; Vukusic S; Graus F; Honnorat J; Confavreux C
Arch Neurol; 2010 May; 67(5):627-30. PubMed ID: 20457964
[TBL] [Abstract][Full Text] [Related]
8. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2.
Ruiz-García R; Martínez-Hernández E; Joubert B; Petit-Pedrol M; Pajarón-Boix E; Fernández V; Salais L; Del Pozo M; Armangué T; Sabater L; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826987
[TBL] [Abstract][Full Text] [Related]
10. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
[TBL] [Abstract][Full Text] [Related]
11. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neuroimmunol; 2018 Apr; 317():5-7. PubMed ID: 29501085
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.
Sillevis Smitt P; Kinoshita A; De Leeuw B; Moll W; Coesmans M; Jaarsma D; Henzen-Logmans S; Vecht C; De Zeeuw C; Sekiyama N; Nakanishi S; Shigemoto R
N Engl J Med; 2000 Jan; 342(1):21-7. PubMed ID: 10620645
[No Abstract] [Full Text] [Related]
13. Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.
Lopez-Chiriboga AS; Komorowski L; Kümpfel T; Probst C; Hinson SR; Pittock SJ; McKeon A
Neurology; 2016 Mar; 86(11):1009-13. PubMed ID: 26888994
[TBL] [Abstract][Full Text] [Related]
14. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
15. [Cerebellar Ataxia and Autoantibodies].
Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma.
Iorio R; Damato V; Mirabella M; Vita MG; Hulsenboom E; Plantone D; Bizzarro A; Del Grande A; Sillevis Smitt PA
J Neuroimmunol; 2013 Oct; 263(1-2):155-8. PubMed ID: 23958353
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
Planche V; Marques A; Ulla M; Ruivard M; Durif F
Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
20. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
